A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

Summary

This open-label, Phase 1 study will investigate the 5-hydroxytryptamine 6 (5-HT6) receptor occupancy in the brain using positron emission tomography (PET) following single oral doses of SLV354. Up to 22 healthy male subjects and male subjects with stable schizophrenia, between 18-55 years of age are to complete the study.

Timeline

Start

2011-05

Primary completion

2012-07

Completion

2012-07

Drugs

Indications